Sun Pharma secures global licensing for Lerodalcibep, a PCSK9 inhibitor, to expand its Innovative Medicines portfolio and address cardiovascular care needs.
Ipca Laboratories (IPCALAB) partners with Bhami’s Research Laboratory for global licensing of novel subcutaneous biologics delivery technology.